Mardi Dier
EVP and CFO · 2 filings · Latest: Mar 4, 2026
MADRIGAL PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MDGL | Mardi Dier | EVP and CFO | Mar 6, 2026 | Sale | $430.87 | 1,982 | $854.0K | 12,490 | |
MDGL | Mardi Dier | — | Mar 6, 2026 | Proposed Sale | $439.34 | 646 | $283.8K | — | |
MDGL | MARDI DIER | — | Mar 6, 2026 | Proposed Sale | $439.34 | 1,336 | $587.0K | — | |
MDGL | Mardi Dier | EVP and CFO | Mar 2, 2026 | Sale | $427.21 | 1,183 | $505.4K | 9,257 | |
MDGL | Mardi Dier | — | Mar 2, 2026 | Proposed Sale | $432.00 | 1,183 | $511.1K | — | |
MDGL | MARDI C DIER | — | Dec 2, 2025 | Proposed Sale | $579.45 | 4,173 | $2.4M | — | |
MDGL | Mardi Dier | — | Mar 10, 2025 | Proposed Sale | $323.63 | 2,219 | $718.1K | — |